Journal Article Summary
The article discusses a case of acute akathisia, a condition characterized by a feeling of inner restlessness, that occurred in a 76-year-old man following the initiation of opicapone, a medication used to treat Parkinson's disease. This topic is significant because akathisia can severely impact the quality of life for patients with Parkinson's disease, and understanding its potential triggers is crucial for effective management. The case highlights the need for healthcare providers to be aware of this adverse effect, especially when introducing new medications.
In this case, the patient had a long history of Parkinson's disease and was prescribed opicapone to help manage his symptoms. After taking the medication for three days, he developed symptoms including restlessness, anxiety, and difficulty breathing, which led to multiple emergency department visits. Upon evaluation, healthcare providers suspected he was experiencing acute akathisia, leading to the discontinuation of opicapone and treatment with lorazepam and trihexyphenidyl, which ultimately alleviated his symptoms.
The article notes several limitations, including the rarity of reported cases of akathisia following the use of opicapone, which may hinder broader conclusions about its prevalence. Patients and caregivers should be aware of the potential for akathisia when starting new medications for Parkinson's disease and discuss any unusual symptoms with a healthcare professional promptly. It is essential to monitor for side effects and adjust treatment plans accordingly to ensure patient safety and comfort.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Baumgartner Alexander J., Adkins Michelle, Bainbridge Jacquelyn, Leehey Maureen A.. Acute akathisia following initiation of opicapone: A case report. Clinical Parkinsonism & Related Disorders 2022. DOI: 10.1016/j.prdoa.2022.100154. PMID: 35898798. PMCID: PMC9310131.
Featured Pill Pals Product
Benztropine 0.5 mg Tablets --- Generic For Cogentin --- Leading Pharma
Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
